Clinical Trial

Glucose Profiles in Women With Polycystic Ovary Syndrome

Study acronym: PROGLYSOPK
Recruiting
View on ClinicalTrials.gov →
Summary
Polycystic ovary syndrome is a very common condition that is associated with metabolic complications. Patients with polycystic ovary syndrome exhibit insulin resistance and are at greater risk to develop type 2 diabetes. This syndrome is heterogeneous, classified according to 4 phenotypes (A-D). It seems that certain phenotypes are less exposed to insulin resistance and metabolic complications. However, only a few studies have evaluated the glucose profile according to phenotype. New technologies now make it possible to monitor glucose levels continuously. The aim of this project is to evaluate glucose profile parameters using continuous glucose monitoring, and to compare these profiles according to different PCOS phenotypes.
Trial Details
NCT Number NCT07483723
Lead Sponsor Centre Hospitalier Universitaire, Amiens
Conditions Polycystic Ovary Syndrome, Glucose Profile, Insulin Resistance, Continuous Glucose Monitoring
Enrollment 80 participants
Start Date 2026-01-06
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-19